by Jody Ranck | July 23, 2019
Precision medicine (PM) is of growing importance in healthcare and was the focus of a major push by the Obama Administration through the Precision Medicine Initiative (PMI) launched in 2015. Chilmark uses Ferryman and Pitcain’s definition of precision medicine as the “effort to collect, integrate, and analyze multiple sources of genetic
by Hannah Ehnle | June 11, 2019
Recently, Senior Analyst Alex Lennox-Miller was a guest on This Just In, a radio show and podcast with HIT Advisor Justin Barnes. Over two episodes, Alex and Justin discuss the driving forces and strategies behind new healthcare delivery and business models, particularly in primary care as Alex has explores elsewhere as
by Robert Tholemeier | April 30, 2019
Three years ago, our report Making Healthcare Affordable: Implementing True Continuous Costing explored the need for, and benefits of, implementing True Continuous Costing (TCC). TCC is an analytics approach to measuring a provider’s costs of providing care for each patient encounter using the data healthcare providers already have. Since then
by Matt Guldin | January 23, 2019
Key Takeaways: Walgreens ‘front door to care’ strategy is built around multiple horizontal partnerships. There are questions about how quickly these partnerships can scale to meet investors’ concerns and how Walgreens will monetize them. It is unclear how this new Microsoft partnership announcement fits in with the Walgreens digital consumer
by John Moore | January 21, 2019
Once again, it is that time of the year for our annual pilgrimage to HIMSS. While many attendees focus on the sheer size of the exhibit hall or packing their schedule full of meetings, we wanted to highlight the other major part of the event: education sessions. Below are this
by Hannah Ehnle | January 14, 2019
Last month, Alex Lennox-Miller joined Chilmark Research as our newest analyst. He will lead our research on population health management, though he is already helping out in a few other domains as well. Before Chilmark, Alex worked as a Senior Business Analyst at Lahey Health System, a provider organization with
by Chilmark Team | December 10, 2018
The Meaningful Use gravy train finally came to an end in 2018. As the strongest EHR vendors struggle to define new revenue streams, weaker ones faded from view through acquisitions or leveraged buy-out. Meanwhile, funding for 'digital health' start-ups continued to increase, though it likely hit the high water mark
by Chilmark Team | November 29, 2018
As is our custom here, we like to look back on our predictions for the closing year and see just how well we did. Some years we do amazingly well, others we over-reach and miss on quite a few. For 2018, we got seven of our 13 predictions spot-on, two
